These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Vaccine against SARS-CoV-2 in previously infected health care workers. Parisi SG EBioMedicine; 2021 Sep; 71():103556. PubMed ID: 34454402 [No Abstract] [Full Text] [Related]
6. Role of antibody-dependent enhancement (ADE) in the virulence of SARS-CoV-2 and its mitigation strategies for the development of vaccines and immunotherapies to counter COVID-19. Karthik K; Senthilkumar TMA; Udhayavel S; Raj GD Hum Vaccin Immunother; 2020 Dec; 16(12):3055-3060. PubMed ID: 32845733 [TBL] [Abstract][Full Text] [Related]
7. How nano can fight the virus. Ball P Nat Mater; 2021 Feb; 20(2):126. PubMed ID: 33504984 [No Abstract] [Full Text] [Related]
9. SARS-CoV-2 Vaccines: Much Accomplished, Much to Learn. Connors M; Graham BS; Lane HC; Fauci AS Ann Intern Med; 2021 May; 174(5):687-690. PubMed ID: 33460347 [TBL] [Abstract][Full Text] [Related]
10. Nanocarrier vaccines for SARS-CoV-2. Machhi J; Shahjin F; Das S; Patel M; Abdelmoaty MM; Cohen JD; Singh PA; Baldi A; Bajwa N; Kumar R; Vora LK; Patel TA; Oleynikov MD; Soni D; Yeapuri P; Mukadam I; Chakraborty R; Saksena CG; Herskovitz J; Hasan M; Oupicky D; Das S; Donnelly RF; Hettie KS; Chang L; Gendelman HE; Kevadiya BD Adv Drug Deliv Rev; 2021 Apr; 171():215-239. PubMed ID: 33428995 [TBL] [Abstract][Full Text] [Related]
11. Innovators target vaccines for variants and shortages in global South. Sheridan C Nat Biotechnol; 2021 Apr; 39(4):393-396. PubMed ID: 33731936 [No Abstract] [Full Text] [Related]
12. COVID-19 vaccines for patients with haematological conditions. Sun C; Pleyer C; Wiestner A Lancet Haematol; 2021 May; 8(5):e312-e314. PubMed ID: 33811822 [No Abstract] [Full Text] [Related]
13. Vaccines for COVID-19: perspectives from nucleic acid vaccines to BCG as delivery vector system. de Queiroz NMGP; Marinho FV; Chagas MA; Leite LCC; Homan EJ; de Magalhães MTQ; Oliveira SC Microbes Infect; 2020; 22(10):515-524. PubMed ID: 32961274 [TBL] [Abstract][Full Text] [Related]
14. COVID-19 - Recent advancements in identifying novel vaccine candidates and current status of upcoming SARS-CoV-2 vaccines. Iqbal Yatoo M; Hamid Z; Parray OR; Wani AH; Ul Haq A; Saxena A; Patel SK; Pathak M; Tiwari R; Malik YS; Sah R; Rabaan AA; Rodriguez Morales AJ; Dhama K Hum Vaccin Immunother; 2020 Dec; 16(12):2891-2904. PubMed ID: 32703064 [TBL] [Abstract][Full Text] [Related]
15. Messenger RNA vaccines against SARS-CoV-2. Topol EJ Cell; 2021 Mar; 184(6):1401. PubMed ID: 33740443 [TBL] [Abstract][Full Text] [Related]
16. COVID-19 vaccines and decreased transmission of SARS-CoV-2. Vitiello A; Ferrara F; Troiano V; La Porta R Inflammopharmacology; 2021 Oct; 29(5):1357-1360. PubMed ID: 34279767 [TBL] [Abstract][Full Text] [Related]
18. Repurposing CD8 Gujar S; Pol JG; Kim Y; Kroemer G Oncoimmunology; 2020 Jul; 9(1):1794424. PubMed ID: 32923158 [TBL] [Abstract][Full Text] [Related]
19. Measuring cellular and humoral immunogenicity of a SARS-CoV-2 mRNA vaccine (BNT126b2) in patients on maintenance haemodialysis. Martin P; Clarke C EBioMedicine; 2021 Sep; 71():103567. PubMed ID: 34454401 [No Abstract] [Full Text] [Related]
20. Recent advances in therapeutic modalities and vaccines to counter COVID-19/SARS-CoV-2. Bilal M; Iqbal HMN Hum Vaccin Immunother; 2020 Dec; 16(12):3034-3042. PubMed ID: 32845742 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]